Sell PRA Health Sciences (NSDQ: PRAH) for 35% Gain

By Linda McDonough • June 18, 2018

Sell PRA Health Sciences (NSDQ: PRAH) for a 35% gain.

It’s had a monster run in the past month (up 20%) but estimates have not budged.

I still like the fundamentals but cannot justify a higher target. Subscribers who want to hold on to this stock might consider placing a $92-94 stop loss on their position. The stock generated a 35% gain in the 13 months since my buy recommendation in May 2017.

Stock Talk

Comments Oldest First

Comments Guidelines

Ted

06/18/18 ‐ 11:51am ET June 18, 2018 at 11:51am ET

I just want to mention that I didn’t get a text alert on this. OFI had this issue on Friday and many of us didn’t receive the alert until near or after market close and the trade needed to be executed that day. I hope someone is looking into these issues.

Ted

06/18/18 ‐ 12:01pm ET June 18, 2018 at 12:01pm ET

Update – the text came 12pm, email notice was at 10:25 eastern time.

Linda McDonough

06/18/18 ‐ 12:03pm ET June 18, 2018 at 12:03pm ET

Hmmmm….thank you for the notice Ted. I’ll pass along to our IT staff and have them investigate and hopefully rectify the lag.
Best,
Linda

Add New Comments

You must be logged in to post to Stock Talk

About The Author

Linda McDonough

Bio | Archive

Linda McDonough is a veteran hedge fund analyst who loves to break down company financial statements and identify market inefficiencies to uncover big opportunities. She believes in a boots-on-the-ground approach that includes surveying customers, interviewing company executives, or doing whatever it takes to see what others don't.

She's now brought her experience as a hedge fund analyst to subscribers of her Profit Catalyst Alert service. Her system identifies small- and mid-cap stocks that are about to move due to catalytic events that few others can identify...until it's too late. These events often times result in massive gains for her followers.